Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04617678 · ClinicalTrials.gov registry record · NA

A Comprehensive Approach to Head and Neck Cancer Prehabilitation

A NA study of Cancer of Head and Neck, sponsored by Sanford Health.

Active
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT04617678 is a NA study of Cancer of Head and Neck that is active but no longer recruiting, run by Sanford Health. The registered enrollment target is 80 participants, below the 240-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04617678, a NA study of Cancer of Head and Neck, is active but no longer recruiting, sponsored by Sanford Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

Head and neck cancer accounts for 3% of malignancies in the United States. However, the diagnosis and treatment for head and neck cancer is considered to be debilitating. Not because of its morbidity, but due to the extremely rigorous treatment course which has a profound impact on patients physical, social, and emotional functioning. Disfigurement and sensorimotor deficits further compound this impact. Head and neck cancer patients contend with treatments that can significantly affect their quality of life. Treatment regularly results in decreased functional capacity and decreased quality of life. Physical impairments are manifested through, but not limited to, disfigurement, deconditioning, communication issues, "swallowing, speech, breathing, and cancer-related fatigue". Premorbid factors such as preexisting anxiety and depression, chemical dependency, financial barriers, and lack of social support system are unique obstacles to the head and neck cancer population impacting treatment and outcomes. Due to these factors, patients experience higher rates of anxiety and depression, psychological distress, and fear of cancer recurrence. In fact, "compared with other survivors of cancer, head and neck cancer survivors are almost 2 times more likely to die from suicide". In view of the aforementioned research, Roger Maris Cancer Center's head and neck cancer will implement a prehabilitation program that evaluates each patient using standardized screening tools and provide personalized education and interventions. This project evaluates a more comprehensive and proactive multidisciplinary approach to improve treatment and outcomes in head and neck cancer patients.

Conditions Studied

Cancer of Head and Neck

Interventions

  • OTHER Prehabilitation Program

Study Locations (2)

North Dakota

  • Sanford Health - Fargo

South Dakota

  • Sanford Health - Sioux Falls

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-10-21
Est. Completion 2026-12
Phase NA

Sponsor

Sanford Health

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04617678

The ClinicalTrials.gov registry entry for NCT04617678 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 240-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (67% lower). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Prehabilitation Program is the first listed.

NCT04617678 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Dakota, South Dakota.

Frequently Asked Questions

What is clinical trial NCT04617678 about?

NCT04617678 is a clinical study titled "A Comprehensive Approach to Head and Neck Cancer Prehabilitation". Head and neck cancer accounts for 3% of malignancies in the United States. However, the diagnosis and treatment for head and neck cancer is considered to be debilitating. Not because of its morbidity, but due to the extremely rigorous treatment course which has a profound impact on patients physical...

What is the current status of trial NCT04617678?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-10-21. Estimated completion is 2026-12.

What conditions does trial NCT04617678 study?

This clinical trial studies the following conditions: Cancer of Head and Neck.

What interventions are being tested in trial NCT04617678?

The interventions under investigation include: Prehabilitation Program (OTHER).

Who is sponsoring clinical trial NCT04617678?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04617678 being conducted?

This trial has 2 study locations across North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer of Head and Neck

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer of Head and Neck

All registered trials for this condition

North Dakota

All trials with a study site in North Dakota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.